Please disable your Ad Blocker to better interact with this website.

Product Recall PSAs Recall Alerts

Birth Control Pills Recalled After Packaging Error Places Them Out of Order

birth control recall

Consumers are being warned of a recall involving a popular brand of birth control pills after a packaging error could result in an unplanned pregnancy.

According to the manufacturer, four placebo pills that were supposed to be packed at the end of the month instead of the beginning. This could result in pregnancy in some patients. Anyone concerned that they may have affected product should check the photos and lot number below for more information.

The recall applies to Taytulla, and includes one month sample packs that physicians gave patients to start their birth control pill plan.

take our poll - story continues below

What is your top alternative to Facebook? - FIXED

  • What is your top alternative to Facebook?  

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to Public Service Alerts updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

Allergan, the maker of Taytulla, released this statement on the birth control pill recall.

Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6×28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

As a result of this packaging error, oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy. The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order. If patients have concerns regarding the possibility of an unintended pregnancy they should consult their physician.

This product is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives. The TAYTULLA pill pack is a 28 count blister card that has 24 “active” pink softgel capsules (with hormones) with “WC” printed on the outer shell in white to be taken for 24 days, followed by 4 maroon softgel capsules (without hormones) also imprinted with “WC” on one side to be taken for the next four days. If you are a patient in the U.S. who has used a TAYTULLA sample pack from lot 5620706, Exp. May 2019 since August 27, 2017, and are concerned that you may be impacted by this issue, please consult with your physician. This product was distributed Nationwide to healthcare providers.

Please refer to the affected lot number as well as the pictures below of the affected product.

birth control recall

 

Allergan is notifying customers by recall letter and is arranging for return of all recalled sample pack product with the lot #5620706 Exp. May 2019. Consumers who have the sample pack product with the associated lot number should notify their physician to arrange a return.

Consumers with questions regarding this recall can contact Allergan by phone at 800-678-1605 8am-8pm EST Monday through Friday. Consumers should contact their physician or healthcare provider if they have questions.

Adverse events or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm
Regular Mail or Fax: download form www.fda.gov/MedWatch/getforms.htm or call 1-800-FDA-1088 to request form, then complete and return address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the US Food and Drug Administration (FDA)

For more information about TAYTULLA and the full prescribing information, please visit www.taytulla.com.

Company Contact / Customers: 1-800-678-1605

Here is a picture of the product, both incorrectly packaged, and the correct version.

birth control recall

Pass along this birth control pill recall notice to anyone you think might be affected. In addition, share this on social media.

 

 

Join the conversation!

We have no tolerance for comments containing violence, racism, vulgarity, profanity, all caps, or discourteous behavior. Thank you for partnering with us to maintain a courteous and useful public environment where we can engage in reasonable discourse.

Trending Now on Public Service Alerts

Send this to a friend